These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 21316753

  • 1. Lowering blood pressure in acute stroke: the SCAST trial.
    Hankey GJ.
    Lancet; 2011 Feb 26; 377(9767):696-8. PubMed ID: 21316753
    [No Abstract] [Full Text] [Related]

  • 2. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
    Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group.
    Lancet; 2011 Feb 26; 377(9767):741-50. PubMed ID: 21316752
    [Abstract] [Full Text] [Related]

  • 3. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL, Atar D, Hanley DF.
    Cerebrovasc Dis; 2008 Feb 26; 26(5):563-4. PubMed ID: 18936537
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of high blood pressure in acute stroke--the SCAST study.
    Kjeldsen SE, Hedner T, Narkiewicz K, Oparil S.
    Blood Press; 2011 Apr 26; 20(2):67-8. PubMed ID: 21405956
    [No Abstract] [Full Text] [Related]

  • 5. The X-cellent Study.
    Safar ME.
    Am J Hypertens; 2006 Jan 26; 19(1):8-9. PubMed ID: 16461182
    [No Abstract] [Full Text] [Related]

  • 6. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
    Nakamura T, Tsutsumi Y, Shimizu Y, Uchiyama S.
    J Stroke Cerebrovasc Dis; 2010 Jan 26; 19(6):435-40. PubMed ID: 20702114
    [Abstract] [Full Text] [Related]

  • 7. Blood pressure management in acute stroke: does the Scandinavian Candesartan Acute Stroke Trial (SCAST) resolve all of the unanswered questions?
    Fischer U, Rothwell PM.
    Stroke; 2011 Oct 26; 42(10):2995-8. PubMed ID: 21852619
    [No Abstract] [Full Text] [Related]

  • 8. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
    MMW Fortschr Med; 2003 Apr 10; 145(15):62. PubMed ID: 15104271
    [No Abstract] [Full Text] [Related]

  • 9. [In view of the findings of the SCAST study, must the treatment of arterial pressure in the acute phase of stroke be changed?].
    Castilla-Guerra L, Fernández-Moreno MC, Álvarez-Suero J, Jiménez Hernández MD.
    Rev Neurol; 2011 Dec 16; 53(12):766-7. PubMed ID: 22127665
    [No Abstract] [Full Text] [Related]

  • 10. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
    Zeller A, Battegay E.
    Praxis (Bern 1994); 2005 Apr 13; 94(15):581-94. PubMed ID: 15884724
    [Abstract] [Full Text] [Related]

  • 11. Stroke: blood pressure lowering in acute stroke--scant joy from SCAST.
    Arima H, Chalmers J.
    Nat Rev Cardiol; 2011 Apr 26; 8(7):366-8. PubMed ID: 21587216
    [No Abstract] [Full Text] [Related]

  • 12. ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
    Oparil S, Kjeldsen SE, Hedner T, Narkiewicz K.
    Blood Press; 2009 Apr 26; 18(1-2):4-6. PubMed ID: 19191085
    [No Abstract] [Full Text] [Related]

  • 13. An overview of candesartan in clinical practice.
    Khawaja Z, Wilcox CS.
    Expert Rev Cardiovasc Ther; 2011 Aug 26; 9(8):975-82. PubMed ID: 21878042
    [Abstract] [Full Text] [Related]

  • 14. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47. PubMed ID: 19528888
    [No Abstract] [Full Text] [Related]

  • 15. Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome.
    Sandset EC, Murray GD, Bath PM, Kjeldsen SE, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group.
    Stroke; 2012 Aug 15; 43(8):2108-14. PubMed ID: 22627991
    [Abstract] [Full Text] [Related]

  • 16. [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with candesartan/HCTZ].
    Bramlage P, Schönrock E, Odoj P, Wolf WP, Funken C.
    MMW Fortschr Med; 2008 Feb 07; 150(6):40. PubMed ID: 18323344
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of high-normal blood pressure with angiotensin receptor blockers. TROPHY Study (Trial of Preventing Hypertension)].
    Mann J.
    Internist (Berl); 2007 Apr 07; 48(4):436-8. PubMed ID: 17342351
    [No Abstract] [Full Text] [Related]

  • 18. Blood pressure variability: the challenge of variation.
    Marshall TP.
    Am J Hypertens; 2008 Jan 07; 21(1):3-4. PubMed ID: 18091733
    [No Abstract] [Full Text] [Related]

  • 19. New data on ONTARGET: more confusion?
    Escobar C, Echarri R, Barrios V.
    J Clin Hypertens (Greenwich); 2010 Mar 07; 12(3):199. PubMed ID: 20433538
    [No Abstract] [Full Text] [Related]

  • 20. [Study on cognition and prognosis in the elderly].
    Kohara K.
    Nihon Rinsho; 2006 Aug 07; 64 Suppl 6():425-30. PubMed ID: 16981574
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.